Skip to main content

Dapagliflozin

NDC 59651-159 · Aurobindo Pharma Limited

Generic nameDapagliflozin
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)DAPAGLIFLOZIN
Strength5 mg/1
Pharmacologic classSodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]
Marketing categoryANDA

Packages

59651-159-30 — 30 TABLET, FILM COATED in 1 BOTTLE (59651-159-30)

59651-159-90 — 90 TABLET, FILM COATED in 1 BOTTLE (59651-159-90)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

33342-585 — dapagliflozin, 33342-586 — dapagliflozin, 46708-392 — DAPAGLIFLOZIN, 46708-393 — DAPAGLIFLOZIN, 50090-7971 — Dapagliflozin, 50090-7972 — Dapagliflozin, 59651-154 — Dapagliflozin and Metformin hydrochloride, 59651-155 — Dapagliflozin and Metformin hydrochloride, 59651-156 — Dapagliflozin and Metformin hydrochloride, 59651-157 — Dapagliflozin and Metformin hydrochloride, 59651-160 — Dapagliflozin, 60505-4911 — DAPAGLIFLOZIN, 60505-4912 — DAPAGLIFLOZIN, 62332-392 — DAPAGLIFLOZIN, 62332-393 — DAPAGLIFLOZIN, 63304-026 — Dapagliflozin and Metformin Hydrochloride, 63304-027 — Dapagliflozin and Metformin Hydrochloride, 63304-028 — Dapagliflozin and Metformin Hydrochloride, 67877-608 — Dapagliflozin, 67877-609 — Dapagliflozin, +40 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels